Nogapendekin Alfa Inbakicept: A New Drug for Non-Muscle-Invasive Bladder Cancer
Nogapendekin Alfa Inbakicept is the first FDA-approved immunotherapy for BCG-unresponsive NMIBC, helping the body fight bladder cancer.
Dr. Kaushal Bhavsar
